13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-14, with 66 holding rows worth $102,762,727.
- Accession
- 0000935836-25-000328
- Filer
- CIK 1440771
- Filed
- 2025-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 66 entries on the cover page, a total value of $102,762,727 stated on the cover page (in dollars after the unit check, H1), rows summing to $102,762,727 with VALUE read as dollars as filed, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 48,000 | $13,648,925 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 1,134,574 | $13,648,925 | dollars as filed | |
| OPTINOSE INC | 68404V209 | COM | 788,647 | $7,231,893 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 650,000 | $4,868,500 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 613,000 | $3,696,390 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 333,400 | $3,687,404 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 285,782 | $3,332,218 | dollars as filed | |
| ANIKA THERAPEUTICS INC | 035255108 | COM | 206,639 | $3,260,896 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 590,742 | $3,260,896 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 200,000 | $3,039,973 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 74,500 | $3,039,973 | dollars as filed | |
| Indivior PLC | G4766E116 | Common Stock | 304,000 | $2,897,120 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 527,842 | $2,766,143 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 348,820 | $2,766,143 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 129,813 | $2,587,173 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 2,055,225 | $2,507,375 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 93,968 | $2,360,476 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 914,973 | $2,003,791 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 796,100 | $1,751,420 | dollars as filed | |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 687,500 | $1,677,500 | dollars as filed | |
| MYOMO INC | 62857J201 | COM NEW | 276,707 | $1,330,961 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 100,000 | $1,019,000 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 144,628 | $937,189 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 347,687 | $914,417 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 518,331 | $844,880 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 139,942 | $814,462 | dollars as filed | |
| GERON CORP | 374163103 | COM | 500,000 | $795,000 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 463,721 | $795,000 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 212,783 | $738,357 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 630,183 | $686,899 | dollars as filed | |
| GRACE THERAPEUTICS INC | 00439U104 | COM | 294,550 | $665,683 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 110,000 | $656,700 | dollars as filed | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 20,607 | $615,119 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 367,371 | $615,119 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 200,647 | $603,947 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 131,160 | $581,039 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 102,265 | $561,435 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 620,588 | $500,815 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 100,000 | $488,000 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 167,580 | $413,923 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 483,647 | $398,477 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 68,084 | $394,206 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 238,950 | $346,478 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 95,747 | $343,732 | dollars as filed | |
| RENOVORX INC | 75989R107 | COM NEW | 278,188 | $275,406 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 21,550 | $248,687 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 508,266 | $203,500 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 50,000 | $203,500 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 250,000 | $200,025 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 50,000 | $188,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 35,000 | $185,850 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 93,393 | $185,850 | dollars as filed | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 35,148 | $161,329 | dollars as filed | |
| POLYPID LTD | M8001Q126 | COM | 54,975 | $148,982 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 10,000 | $105,000 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 651,614 | $105,000 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 60,000 | $95,400 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 46,698 | $83,122 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 29,079 | $80,549 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 20,000 | $66,600 | dollars as filed | |
| THERATECHNOLOGIES INC | 88338H704 | COM | 25,825 | $36,155 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 810,000 | $24,300 | dollars as filed | Value about 1/1,000 of the price other filers imply, kept as filed and left out of ratios. |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 5,000 | $24,300 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 10,000 | $18,400 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 10,000 | $14,400 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 102,242 | $14,400 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000935836-25-000328 | this filing | 2025-05-14 | acceptance time not in the bulk data set |